<DOC>
	<DOCNO>NCT01607671</DOCNO>
	<brief_summary>The purpose study evaluate feasibility rapid evaluation administration ophthalmic Timolol maleate treatment non-arteritic anterior ischemic optic neuropathy . Secondary goal evaluate treatment reduces progression improves recovery patient randomly assign treatment versus standard care .</brief_summary>
	<brief_title>Treatment Study Ischemic Optic Neuropathy With Opthalmic Timolol Maleate 0.5 %</brief_title>
	<detailed_description>Non-arteritic anterior ischemic optic neuropathy ( NAION ) currently widely accept acute treatment improve recovery prevent progression first month . It cause monocular vision loss potential second eye involvement 15 % 5 year . This lead significant disability . It common acute optic neuropathy patient 55 year age . The final mechanism injury believe ischemic . Increasing perfusion optic nerve may reduce damage prevent progression . Reduction intraocular pressure show increase optic disc perfusion animal model . Timolol maleate widely use medication Glaucoma reduce intraocular pressure . Treatment Timolol maleate may improve optic disc perfusion NAION reduce ischemic damage condition . This study aim enroll treat patient Timolol maleate 0.5 % within 48 hour symptom onset ass feasibility study design potential benefit rapid intraocular pressure reduction .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Optic Nerve Diseases</mesh_term>
	<mesh_term>Optic Neuropathy , Ischemic</mesh_term>
	<mesh_term>Maleic acid</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<criteria>Age &gt; 40 Sudden , painless monocular vision loss edema optic disc Clinical diagnosis NonArteritic Anterior Ischemic Optic Neuropathy Relative Afferent Pupil Defect ( RAPD ) first study visit Onset vision loss &gt; 48 hour time enrollment History Asthma COPD History Heart Block Sinus Bradycardia Allergy beta blocker History Multiple Sclerosis optic neuropathy Active Ocular Inflammation examination Currently treat Cancer systemic vasculitis History Glaucoma use medication low IOP Symptomatic cataract , retinopathy , macular disease amblyopia symptomatic eye IOP &lt; 10 baseline Ocular surgery past three month Women pregnant , breastfeeding may become pregnant Inability provide inform consent follow three month Currently enrol study drug trial previously enrol study</criteria>
	<gender>All</gender>
	<minimum_age>41 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Ischemic</keyword>
	<keyword>Optic Neuropathy</keyword>
	<keyword>Non-Arteritic Anterior Ischemic Optic Neuropathy</keyword>
	<keyword>NAION</keyword>
	<keyword>Ischemic Optic Neuropathy</keyword>
	<keyword>Intraocular Pressure</keyword>
</DOC>